Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The development, manufacture, and supply of 1 gram of (R)-(N-sec-Butyl)-3-chloromethyl-N-methyl-4-phenylquinoline-2- carboxamide (i.e. [18F]LW223 precursor) alliquoted as 250 x 4 mg as well as 50 mg of (R)-N-(sec-butyl)-3-(fluoromethyl)-N-methyl-4-phenylquinoline-2-carboxamide (i.e. [18F]LW223 standard) for use in clinical trials.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| ABX GmbH | - | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £51,316 initial term | 1 single bid — no competition | ABX GmbH | complete |